Medical - Care Facilities
Compare Stocks
5 / 10Stock Comparison
OPCH vs UNH vs CVS vs HCSG vs MCK
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Plans
Medical - Healthcare Plans
Medical - Care Facilities
Medical - Distribution
OPCH vs UNH vs CVS vs HCSG vs MCK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Care Facilities | Medical - Healthcare Plans | Medical - Healthcare Plans | Medical - Care Facilities | Medical - Distribution |
| Market Cap | $3.25B | $335.60B | $111.40B | $1.60B | $92.15B |
| Revenue (TTM) | $5.67B | $449.71B | $407.90B | $1.84B | $403.43B |
| Net Income (TTM) | $206M | $12.04B | $2.93B | $59M | $4.76B |
| Gross Margin | 18.0% | 18.8% | 13.9% | 13.3% | 3.6% |
| Operating Margin | 5.9% | 4.2% | 1.5% | 3.0% | 1.5% |
| Forward P/E | 11.1x | 20.2x | 12.2x | 20.8x | 19.3x |
| Total Debt | $0.00 | $78.39B | $93.59B | $25M | $7.39B |
| Cash & Equiv. | $233M | $24.36B | $8.51B | $161M | $5.69B |
OPCH vs UNH vs CVS vs HCSG vs MCK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Option Care Health,… (OPCH) | 100 | 136.5 | +36.5% |
| UnitedHealth Group … (UNH) | 100 | 121.3 | +21.3% |
| CVS Health Corporat… (CVS) | 100 | 133.2 | +33.2% |
| Healthcare Services… (HCSG) | 100 | 93.3 | -6.7% |
| McKesson Corporation (MCK) | 100 | 474.1 | +374.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: OPCH vs UNH vs CVS vs HCSG vs MCK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
OPCH has the current edge in this matchup, primarily because of its strength in value and quality.
- Lower P/E (11.1x vs 19.3x)
- 3.6% margin vs CVS's 0.7%
UNH is the clearest fit if your priority is dividends.
- 2.4% yield, 25-year raise streak, vs CVS's 3.1%, (2 stocks pay no dividend)
CVS is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 0 yrs, beta 0.05, yield 3.1%
- Beta 0.05, yield 3.1%, current ratio 0.84x
HCSG is the #2 pick in this set and the best alternative if momentum and efficiency is your priority.
- +55.8% vs OPCH's -37.9%
- 7.3% ROA vs CVS's 1.1%, ROIC 9.0% vs 5.0%
MCK ranks third and is worth considering specifically for growth exposure and long-term compounding.
- Rev growth 16.2%, EPS growth 14.9%, 3Y rev CAGR 10.8%
- 348.1% 10Y total return vs OPCH's 97.2%
- Lower volatility, beta 0.04, current ratio 0.90x
- 16.2% revenue growth vs HCSG's 7.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 16.2% revenue growth vs HCSG's 7.1% | |
| Value | Lower P/E (11.1x vs 19.3x) | |
| Quality / Margins | 3.6% margin vs CVS's 0.7% | |
| Stability / Safety | Beta 0.04 vs HCSG's 1.12 | |
| Dividends | 2.4% yield, 25-year raise streak, vs CVS's 3.1%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +55.8% vs OPCH's -37.9% | |
| Efficiency (ROA) | 7.3% ROA vs CVS's 1.1%, ROIC 9.0% vs 5.0% |
OPCH vs UNH vs CVS vs HCSG vs MCK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
OPCH vs UNH vs CVS vs HCSG vs MCK — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MCK leads in 2 of 6 categories
HCSG leads 1 • OPCH leads 1 • UNH leads 0 • CVS leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HCSG leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UNH is the larger business by revenue, generating $449.7B annually — 244.8x HCSG's $1.8B. Profitability is closely matched — net margins range from 3.6% (OPCH) to 0.7% (CVS). On growth, HCSG holds the edge at +6.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $5.7B | $449.7B | $407.9B | $1.8B | $403.4B |
| EBITDAEarnings before interest/tax | $406M | $23.2B | $10.5B | $72M | $6.8B |
| Net IncomeAfter-tax profit | $206M | $12.0B | $2.9B | $59M | $4.8B |
| Free Cash FlowCash after capex | $244M | $19.7B | $7.4B | $139M | $6.0B |
| Gross MarginGross profit ÷ Revenue | +18.0% | +18.8% | +13.9% | +13.3% | +3.6% |
| Operating MarginEBIT ÷ Revenue | +5.9% | +4.2% | +1.5% | +3.0% | +1.5% |
| Net MarginNet income ÷ Revenue | +3.6% | +2.7% | +0.7% | +3.2% | +1.2% |
| FCF MarginFCF ÷ Revenue | +4.3% | +4.4% | +1.8% | +7.6% | +1.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +1.3% | +2.0% | +6.2% | +6.6% | +6.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +3.6% | +0.7% | +63.1% | +175.0% | +37.0% |
Valuation Metrics
OPCH leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 16.3x trailing earnings, OPCH trades at a 74% valuation discount to CVS's 62.8x P/E. On an enterprise value basis, OPCH's 7.4x EV/EBITDA is more attractive than HCSG's 22.4x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $3.2B | $335.6B | $111.4B | $1.6B | $92.1B |
| Enterprise ValueMkt cap + debt − cash | $3.0B | $389.6B | $196.5B | $1.5B | $93.8B |
| Trailing P/EPrice ÷ TTM EPS | 16.34x | 27.95x | 62.81x | 27.54x | 29.25x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.12x | 20.19x | 12.19x | 20.83x | 19.28x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 0.75x |
| EV / EBITDAEnterprise value multiple | 7.38x | 16.70x | 13.11x | 22.38x | 18.74x |
| Price / SalesMarket cap ÷ Revenue | 0.57x | 0.75x | 0.28x | 0.87x | 0.26x |
| Price / BookPrice ÷ Book value/share | 2.56x | 3.31x | 1.47x | 3.19x | — |
| Price / FCFMarket cap ÷ FCF | 12.56x | 20.88x | 14.27x | 11.49x | 17.63x |
Profitability & Efficiency
MCK leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
MCK delivers a 3.0% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $4 for CVS. HCSG carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to CVS's 1.24x. On the Piotroski fundamental quality scale (0–9), HCSG scores 7/9 vs CVS's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +15.3% | +11.5% | +3.9% | +11.8% | +3.0% |
| ROA (TTM)Return on assets | +6.0% | +3.9% | +1.1% | +7.3% | +5.7% |
| ROICReturn on invested capital | +15.3% | +9.2% | +5.0% | +9.0% | +5.4% |
| ROCEReturn on capital employed | +12.8% | +9.7% | +6.1% | +7.7% | +30.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 5 | 7 | 6 |
| Debt / EquityFinancial leverage | — | 0.77x | 1.24x | 0.05x | — |
| Net DebtTotal debt minus cash | -$233M | $54.0B | $85.1B | -$136M | $1.7B |
| Cash & Equiv.Liquid assets | $233M | $24.4B | $8.5B | $161M | $5.7B |
| Total DebtShort + long-term debt | $0 | $78.4B | $93.6B | $25M | $7.4B |
| Interest CoverageEBIT ÷ Interest expense | 5.50x | 4.71x | 2.11x | 33.02x | 33.79x |
Total Returns (Dividends Reinvested)
MCK leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MCK five years ago would be worth $38,689 today (with dividends reinvested), compared to $7,888 for HCSG. Over the past 12 months, HCSG leads with a +55.8% total return vs OPCH's -37.9%. The 3-year compound annual growth rate (CAGR) favors MCK at 27.3% vs OPCH's -9.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -35.6% | +10.6% | +10.6% | +28.6% | -8.5% |
| 1-Year ReturnPast 12 months | -37.9% | -3.2% | +34.7% | +55.8% | +4.6% |
| 3-Year ReturnCumulative with dividends | -26.3% | -19.9% | +36.6% | +48.6% | +106.4% |
| 5-Year ReturnCumulative with dividends | +18.0% | -2.6% | +17.0% | -21.1% | +286.9% |
| 10-Year ReturnCumulative with dividends | +97.2% | +220.6% | +3.5% | -26.8% | +348.1% |
| CAGR (3Y)Annualised 3-year return | -9.7% | -7.1% | +11.0% | +14.1% | +27.3% |
Risk & Volatility
Evenly matched — CVS and MCK each lead in 1 of 2 comparable metrics.
Risk & Volatility
MCK is the less volatile stock with a 0.04 beta — it tends to amplify market swings less than HCSG's 1.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CVS currently trades 98.5% from its 52-week high vs OPCH's 56.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.48x | 0.59x | 0.05x | 1.12x | 0.04x |
| 52-Week HighHighest price in past year | $36.80 | $395.52 | $88.63 | $24.39 | $999.00 |
| 52-Week LowLowest price in past year | $18.01 | $234.60 | $58.35 | $12.66 | $637.00 |
| % of 52W HighCurrent price vs 52-week peak | +56.4% | +93.5% | +98.5% | +91.5% | +75.3% |
| RSI (14)Momentum oscillator 0–100 | 22.5 | 75.9 | 69.3 | 61.8 | 16.2 |
| Avg Volume (50D)Average daily shares traded | 2.4M | 7.9M | 7.4M | 676K | 757K |
Analyst Outlook
Evenly matched — UNH and CVS each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: OPCH as "Buy", UNH as "Buy", CVS as "Buy", HCSG as "Hold", MCK as "Buy". Consensus price targets imply 59.0% upside for OPCH (target: $33) vs 4.2% for UNH (target: $385). For income investors, CVS offers the higher dividend yield at 3.06% vs MCK's 0.36%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $33.00 | $385.43 | $95.20 | $24.50 | $1006.50 |
| # AnalystsCovering analysts | 14 | 52 | 41 | 15 | 31 |
| Dividend YieldAnnual dividend ÷ price | — | +2.4% | +3.1% | — | +0.4% |
| Dividend StreakConsecutive years of raises | 1 | 25 | 0 | 20 | 17 |
| Dividend / ShareAnnual DPS | — | $8.70 | $2.67 | — | $2.69 |
| Buyback YieldShare repurchases ÷ mkt cap | +9.5% | +1.7% | 0.0% | +3.9% | +3.4% |
MCK leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). HCSG leads in 1 (Income & Cash Flow). 2 tied.
OPCH vs UNH vs CVS vs HCSG vs MCK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is OPCH or UNH or CVS or HCSG or MCK a better buy right now?
For growth investors, McKesson Corporation (MCK) is the stronger pick with 16.
2% revenue growth year-over-year, versus 7. 1% for Healthcare Services Group, Inc. (HCSG). Option Care Health, Inc. (OPCH) offers the better valuation at 16. 3x trailing P/E (11. 1x forward), making it the more compelling value choice. Analysts rate Option Care Health, Inc. (OPCH) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — OPCH or UNH or CVS or HCSG or MCK?
On trailing P/E, Option Care Health, Inc.
(OPCH) is the cheapest at 16. 3x versus CVS Health Corporation at 62. 8x. On forward P/E, Option Care Health, Inc. is actually cheaper at 11. 1x.
03Which is the better long-term investment — OPCH or UNH or CVS or HCSG or MCK?
Over the past 5 years, McKesson Corporation (MCK) delivered a total return of +286.
9%, compared to -21. 1% for Healthcare Services Group, Inc. (HCSG). Over 10 years, the gap is even starker: MCK returned +348. 1% versus HCSG's -26. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — OPCH or UNH or CVS or HCSG or MCK?
By beta (market sensitivity over 5 years), McKesson Corporation (MCK) is the lower-risk stock at 0.
04β versus Healthcare Services Group, Inc. 's 1. 12β — meaning HCSG is approximately 2507% more volatile than MCK relative to the S&P 500. On balance sheet safety, Healthcare Services Group, Inc. (HCSG) carries a lower debt/equity ratio of 5% versus 124% for CVS Health Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — OPCH or UNH or CVS or HCSG or MCK?
By revenue growth (latest reported year), McKesson Corporation (MCK) is pulling ahead at 16.
2% versus 7. 1% for Healthcare Services Group, Inc. (HCSG). On earnings-per-share growth, the picture is similar: Healthcare Services Group, Inc. grew EPS 52. 8% year-over-year, compared to -62. 0% for CVS Health Corporation. Over a 3-year CAGR, OPCH leads at 12. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — OPCH or UNH or CVS or HCSG or MCK?
Option Care Health, Inc.
(OPCH) is the more profitable company, earning 3. 7% net margin versus 0. 4% for CVS Health Corporation — meaning it keeps 3. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OPCH leads at 6. 0% versus 1. 2% for MCK. At the gross margin level — before operating expenses — UNH leads at 18. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is OPCH or UNH or CVS or HCSG or MCK more undervalued right now?
On forward earnings alone, Option Care Health, Inc.
(OPCH) trades at 11. 1x forward P/E versus 20. 8x for Healthcare Services Group, Inc. — 9. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OPCH: 59. 0% to $33. 00.
08Which pays a better dividend — OPCH or UNH or CVS or HCSG or MCK?
In this comparison, CVS (3.
1% yield), UNH (2. 4% yield), MCK (0. 4% yield) pay a dividend. OPCH, HCSG do not pay a meaningful dividend and should not be held primarily for income.
09Is OPCH or UNH or CVS or HCSG or MCK better for a retirement portfolio?
For long-horizon retirement investors, CVS Health Corporation (CVS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
05), 3. 1% yield). Both have compounded well over 10 years (CVS: +3. 5%, HCSG: -26. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between OPCH and UNH and CVS and HCSG and MCK?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: OPCH is a small-cap deep-value stock; UNH is a large-cap quality compounder stock; CVS is a mid-cap income-oriented stock; HCSG is a small-cap quality compounder stock; MCK is a mid-cap high-growth stock. UNH, CVS pay a dividend while OPCH, HCSG, MCK do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.